OSE Pharma (France) Probability of Future Stock Price Finishing Under 10.36
| OSE Stock | EUR 7.80 0.41 4.99% |
OSE |
OSE Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of OSE Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for OSE Pharma SA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| OSE Pharma SA had very high historical volatility over the last 90 days | |
| The company reported the revenue of 26.31 M. Net Loss for the year was (16.85 M) with profit before overhead, payroll, taxes, and interest of 26.31 M. | |
| OSE Pharma SA has accumulated about 33.58 M in cash with (9.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84. | |
| Roughly 39.0% of the company outstanding shares are owned by corporate insiders |
OSE Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of OSE Stock often depends not only on the future outlook of the current and potential OSE Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. OSE Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 31.4 M | |
| Cash And Short Term Investments | 33.6 M |
OSE Pharma Technical Analysis
OSE Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. OSE Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of OSE Pharma SA. In general, you should focus on analyzing OSE Stock price patterns and their correlations with different microeconomic environments and drivers.
OSE Pharma Predictive Forecast Models
OSE Pharma's time-series forecasting models is one of many OSE Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary OSE Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about OSE Pharma SA
Checking the ongoing alerts about OSE Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for OSE Pharma SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| OSE Pharma SA had very high historical volatility over the last 90 days | |
| The company reported the revenue of 26.31 M. Net Loss for the year was (16.85 M) with profit before overhead, payroll, taxes, and interest of 26.31 M. | |
| OSE Pharma SA has accumulated about 33.58 M in cash with (9.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.84. | |
| Roughly 39.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in OSE Stock
OSE Pharma financial ratios help investors to determine whether OSE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OSE with respect to the benefits of owning OSE Pharma security.